Joël Crouzet

No open positions remaining

68 year

Health Technology

Process Industries

Finance

Profile

Joël Crouzet was the founder of Minka Therapeutics SA, serving as Chief Executive & Scientific Officer from 2011 to 2014, founded in 2008.
Dr. Crouzet was the founder of Ermium Therapeutics SAS, serving as Chief Executive Officer, founded in 2019.
Former job at INSERM Transfert SA as Chief Executive Officer.
Former job at Rhone Poulenc Rorer from 1990 to 1996 as Departmental Director.
Former job at NeuroTECH SA as Research Director.
Education includes a doctorate from Institut National Agronomique Paris-Grignon.

Former positions of Joël Crouzet

Companies	Position	End
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	President	31/08/2008
Rhone Poulenc Rorer Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products.	Corporate Officer/Principal	-
Ermium Therapeutics SAS Ermium Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for auto-immune diseases	Chief Executive Officer	-
NeuroTECH SA NeuroTECH SA Medical SpecialtiesHealth Technology Designs, develops, manufactures, and markets active implantable medical devices	Chief Tech/Sci/R&D Officer	-
Minka Therapeutics SA Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS	Chief Executive Officer	-

See the detail of Joël Crouzet's experience

Training of Joël Crouzet

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joël Crouzet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Rhone Poulenc Rorer Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products.	Process Industries
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
Institut National Agronomique Paris-Grignon Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NeuroTECH SA NeuroTECH SA Medical SpecialtiesHealth Technology Designs, develops, manufactures, and markets active implantable medical devices	Health Technology
Minka Therapeutics SA Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS	Health Technology
Ermium Therapeutics SAS Ermium Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for auto-immune diseases	Health Technology